CELH
Celsius Holdings, Inc.
CELH's fundamentals are strong and it looks cheap: trading at 35x earnings, less than half its usual 142x. Analysts expect strong earnings growth, though they disagree widely on how much.
DEO
Diageo plc
There isn't enough reported data to score DEO yet.
CELH Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Strong | |
| Stable | |
| Strong |
CELH's revenue, profitability and balance sheet are currently healthy, and its cash flow is stable.
DEO Fundamentals
| Metric | Status |
|---|---|
| Unavailable | |
| Stable | |
| Unavailable | |
| Unavailable |
DEO's profitability is currently stable. There isn't enough data to rate its revenue, cash flow and balance sheet.
CELH PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Forward | 21x | $31.89 | — |
| Current | 35x | $31.89 | — |
| Cheap | 40x | $35.95 | +13% |
| Fair | 141x | $127 | +299% |
| Expensive | 650x | $585 | +1735% |
Historical ranges are pointers, not guarantees.
CELH has the edge over DEO in the historical PE scenario, which offers more potential upside but is not a forecast.
DEO PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 18x | $19.27 | -81% |
| Fair | 23x | $24.76 | -75% |
| Current | 23x | $99.99 | — |
| Expensive | 36x | $38.83 | -61% |
Historical ranges are pointers, not guarantees.
DEO's PE is 23x, but its earnings don't support one, so it isn't a reliable read right now.
CELH Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Strong growth | |
| Growth | |
| Improving | |
| Limited | |
| Low |
Analysts expect earnings and revenue growth for CELH, with profitability improving. However, they disagree widely on these estimates.
DEO Forward outlook
There aren't enough analyst estimates for DEO to show an outlook.
CELH Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $1.53 | +70% |
| Q3 2026 | $0.90 | +718% |
| Q2 2026 | $0.24 | -37% |
| Q1 2026 | $0.43 | +30% |
| Q4 2025 | $0.25 | -44% |
| Q3 2025 | $0.11 | -85% |
| Q2 2025 | $0.38 | -62% |
| Q1 2025 | $0.33 | -64% |
| Q4 2024 | $0.45 | -42% |
CELH has the edge over DEO in the latest year-over-year earnings comparison.
DEO Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q4 2025 | $1.08 | -33% |
| Q2 2025 | $1.06 | -39% |
| Q4 2024 | $1.61 | -12% |
| Q2 2024 | $1.73 | -21% |
| Q4 2023 | $1.83 | -12% |
| Q2 2023 | $2.19 | +18% |
| Q4 2022 | $2.08 | +20% |
| Q2 2022 | $1.86 | +23% |
DEO's earnings per share have fallen from their peak: $1.08 over the past year, against $2.19 in mid-2023.
CELH Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $847.2M | +17% |
| Q2 2026 | $817.9M | +11% |
| Q1 2026 | $782.6M | +138% |
| Q4 2025 | $721.6M | +117% |
| Q3 2025 | $725.1M | +173% |
| Q2 2025 | $739.3M | +84% |
| Q1 2025 | $329.3M | -7.4% |
| Q4 2024 | $332.2M | -4.4% |
CELH has the edge over DEO in the latest year-over-year revenue comparison.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 20% | +31 points |
| Q2 2026 | 9.2% | -10 points |
| Q1 2026 | 18% | +2 points |
| Q4 2025 | 3.6% | +9.2 points |
| Q3 2025 | -11% | -9.8 points |
| Q2 2025 | 19% | -4.1 points |
| Q1 2025 | 16% | -7.6 points |
| Q4 2024 | -5.6% | -23 points |
CELH's operating margin was 20% last quarter, up 31 points from the same quarter a year ago.
DEO Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q4 2025 | $14.9B | -2% |
| Q2 2025 | $12.8B | +0.6% |
| Q4 2024 | $15.2B | 0% |
| Q2 2024 | $12.7B | -7.2% |
| Q4 2023 | $15.2B | -14% |
| Q2 2023 | $13.7B | -3.7% |
| Q4 2022 | $17.6B | +12% |
| Q2 2022 | $14.2B | +23% |
DEO's revenue has slid since its 2022 peak: $14.9B last quarter, down 2.1% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q4 2025 | 21% | -0.9 points |
| Q2 2025 | 9.2% | -5.1 points |
| Q4 2024 | 21% | -3.1 points |
| Q2 2024 | 21% | +5.5 points |
| Q4 2023 | 22% | -1.5 points |
| Q2 2023 | 14% | -2.8 points |
| Q4 2022 | 24% | +2.5 points |
| Q2 2022 | 16% | +20 points |
DEO's operating margin was 21% last quarter, down 0.9 points from the same quarter a year ago.
CELH Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $127.7M | -60% |
| Q2 2026 | $205.5M | +479% |
| Q1 2026 | $65.8M | -32% |
| Q4 2025 | -$130M | -285% |
| Q3 2025 | $321.5M | +3599% |
| Q2 2025 | $35.5M | +17% |
| Q1 2025 | $96.4M | -26% |
| Q4 2024 | $70.3M | +16394% |
CELH still generates free cash flow, though less than at its 2025 peak: $269M over the past year.
DEO Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q4 2021 | $2.1B | -10% |
| Q2 2021 | $1.7B | +93% |
| Q4 2020 | $2.3B | +82% |
| Q2 2020 | $880.6M | -49% |
| Q4 2019 | $1.3B | -28% |
| Q2 2019 | $1.7B | +3.1% |
| Q4 2018 | $1.8B | +6.6% |
| Q2 2018 | $1.7B | -4.4% |
DEO's free cash flow has been positive every quarter since mid-2012: $7B over the past year, up 8.8% from the year before.
CELH Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -0.8% | -2M shares |
| 1 year | -1.1% | -2.9M shares |
| 3 years | +7.4% | +17.6M shares |
| 5 years | +8.3% | +19.5M shares |
| Available history | +32% | +62.4M shares |
CELH has the edge over DEO on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | $300,000 |
| Q2 2026 | $1M |
| Q1 2026 | $8.8M |
| Q4 2025 | $2.5M |
| Q3 2025 | $448,000 |
| Q2 2025 | $879,000 |
| Q1 2025 | $1.9M |
| Q4 2024 | $603,000 |
CELH spent $13M buying back its own shares over the past year, about three times what it spent the year before.
DEO Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.1% | +3M shares |
| 1 year | -0.7% | -16M shares |
| 3 years | -5.7% | -135M shares |
| 5 years | +77% | +972M shares |
| Available history | +77% | +972M shares |
DEO has 2.2B diluted shares, down 0.7% from a year ago.
| Quarter | Spent |
|---|---|
| Q2 2019 | $2B |
| Q4 2018 | $1.7B |
| Q2 2018 | $980.4M |
| Q4 2017 | $2B |
| Q2 2017 | $10.6M |
| Q4 2016 | $32.6M |
| Q2 2016 | $665,115 |
| Q4 2015 | $26.6M |
CELH Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | -0.1x | Net Cash |
| Q2 2026 | 0.2x | Very low |
| Q1 2026 | 0.5x | Very low |
| Q4 2025 | 1.6x | Healthy |
| Q3 2025 | 0.5x | Very low |
| Q2 2025 | 1.4x | Healthy |
| Q1 2025 | -7.3x | Net Cash |
| Q4 2024 | -5.5x | Net Cash |
CELH has more cash than debt.
DEO Net Leverage
CELH Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 51.3 | Neutral |
| Stochastic | 56.8 | Neutral |
CELH's weekly RSI is 51 (neutral) and its Stochastic is 57 (neutral).
DEO Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 63.5 | Neutral |
| Stochastic | 83.0 | Overbought |
DEO's weekly RSI is 63 (neutral) and its Stochastic is 83 (overbought).
CELH PE vs Consumer Defensive Sector
| Metric | CELH | Sector median | Relative |
|---|---|---|---|
| PE | 35x | 19x | 82% above |
| PE % | 11 | 18 | 7 pts below |
CELH is trading at 35x earnings, a 82% premium to the Consumer Defensive sector's median of 19x.
DEO PE vs Consumer Defensive Sector
| Metric | DEO | Sector median | Relative |
|---|---|---|---|
| PE | 23x | 19x | 19% above |
| PE % | 51 | 18 | 33 pts above |
DEO has the edge over CELH on valuation relative to its sector.
CELH Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $29.1 | 9.4% above |
| 20 week MA | $29.6 | 7.8% above |
| 50 week MA | $36.1 | 12% below |
| 100 week MA | $38.8 | 18% below |
| 200 week MA | $44.6 | 29% below |
CELH has bounced recently, but its long-term trend is still down: it's above its 8- and 20-week averages, but 29% below its 200-week average.
DEO Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $92.9 | 7.6% above |
| 20 week MA | $90.2 | 11% above |
| 50 week MA | $87.0 | 15% above |
| 100 week MA | $97.0 | 3.1% above |
| 200 week MA | $124.0 | 19% below |
DEO has the edge over CELH on trend strength, trading above more of its moving averages.
CELH Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $1.58 | $14.7 | +832% |
| 2021 | $14.7 | $24.9 | +69% |
| 2022 | $24.9 | $35.6 | +43% |
| 2023 | $35.6 | $54.5 | +53% |
| 2024 | $54.5 | $26.5 | -51% |
| 2025 | $26.5 | $45.6 | +72% |
| 2026 YTD | $45.6 | $31.9 | -30% |
CELH's yearly returns have swung widely, from +832% in 2020 to −51% in 2024. It's down 30% so far in 2026.
DEO Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $169.0 | $159.4 | -5.7% |
| 2021 | $159.4 | $217.1 | +36% |
| 2022 | $217.1 | $180.1 | -17% |
| 2023 | $180.1 | $145.7 | -19% |
| 2024 | $145.7 | $126.9 | -13% |
| 2025 | $126.9 | $86.3 | -32% |
| 2026 YTD | $86.3 | $100.0 | +16% |
DEO has the edge over CELH on returns for 2026, with the stronger performance.